Dalpiciclib With Endocrine Therapy for Advanced Breast Cancer After CDK4/6 Inhibitor Failure (DAWNA-FES)
Clinical trial NCT05861830 · UNKNOWN
Trial details
- NCT number
- NCT05861830
- Sponsor
- Peking Union Medical College Hospital
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-15
- Primary completion
- 2025-12-31
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.